摘要
目的:评价低分子肝素对高脂血症性轻型急性胰腺炎的治疗效果.方法:将86例高脂血症性轻型急性胰腺炎患者随机分为两组,对照组42例给予常规内科治疗,抗凝治疗组44例在常规内科治疗的基础上给予低分子肝素5000U 皮下注射,1次/12小时,观察两组治疗效果.结果:两组患者腹痛缓解时间、C 反应蛋白恢复正常时间及住院时间的比较,差异有显著统计学意义(P〈0.05).结论:在常规内科治疗的基础上联合低分子肝素治疗高脂血症性轻型急性胰腺炎的疗效更为显著,能使患者临床症状较快缓解,缩短病程.
Objective:To evaluate the effects of lower molecular weight heparin (LMWH) in the treatment of patients with hyperlipoidemia mild acute pancreatitis(HLMAP). Methods 86 patients with hyperlipoidemia mild acute pancreatitis were randomly divided into two groups. The 42 patients of control group were given conventional therapy.The 44 patients of anticoagulation
group were given subcutaneous injection of LMWH 5000U every 12h and conventional therapy.The prognosis of patients was detected. Results Time courses of abdominal pain deprivation,return
of C-reactive protein(CRP)levels to normal and hospital stay were significantly different between the two groups(P〈0.05). Conclusion The curative effect which applies LMWH combined with conventional therapy to treat hyperlipoidemia mild acute pancreatitis is very well in clinical symptoms remission and course decurtation.
出处
《湖南中医药大学学报》
CAS
2016年第A02期912-913,共2页
Journal of Hunan University of Chinese Medicine
关键词
高脂血症性轻型急性胰腺炎
低分子肝素
Hyperlipoidemia mild acute pancreatitis
lower molecular weight heparin